Literature DB >> 21342709

Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia.

Masao Moroi1, Akira Yamashina, Kazumasa Tsukamoto, Tsunehiko Nishimura.   

Abstract

BACKGROUND: As an initial management strategy for stable ischemic heart disease (IHD), coronary revascularization therapy is thought to be equal to optimal medical therapy alone regarding prognosis.
METHODS: Whether or not the effects of revascularization on the prognosis of patients with stable IHD are associated with the amount of ischemic myocardium detected by nuclear stress imaging was evaluated. This retrospective study analyzed data from 4629 patients with suspected or known IHD who underwent gated stress myocardial-perfusion SPECT at 117 hospitals in Japan. The follow-up periods were three years and the combined endpoints consisted of cardiac death, nonfatal myocardial infarction, and congestive heart failure requiring hospitalization. After matching propensity scores between patients who underwent early revascularization and those who did not (n=316 per group), we compared cardiac event rates in relation to the amount of ischemic myocardium.
RESULTS: Cardiac event rates did not significantly differ between patients who underwent early revascularization and those who did not (5.4% vs. 6.4%). Among patients with ≤ 5%, 6-10%, and >10% ischemic myocardium, cardiac event rates were 8%, 3% and 0% respectively, who underwent early revascularization compared with 4.5%, 6.1%, and 12.3%, respectively, among those who did not. Cardiac event rates were significantly lower among patients with >10% ischemic myocardium who underwent early revascularization compared with those who did not (0% vs. 12.3%, p=0.0062).
CONCLUSIONS: Coronary revascularization for stable IHD does not decrease major cardiac events in all patients but might do in patients with moderate to severe ischemia.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21342709     DOI: 10.1016/j.ijcard.2011.01.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

Review 1.  Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.

Authors:  Francisco Ujueta; Ephraim N Weiss; Binita Shah; Steven P Sedlis
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

2.  SPECT vs CT: CT is not the first line test for the diagnosis and prognosis of stable coronary artery disease.

Authors:  Zachary J Trzaska; Mylan C Cohen
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

Review 3.  The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?

Authors:  Joe X Xie; David E Winchester; Lawrence M Phillips; Rory Hachamovitch; Daniel S Berman; Ron Blankstein; Marcelo F Di Carli; Todd D Miller; Mouaz H Al-Mallah; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2017-07-27       Impact factor: 5.952

4.  Myocardial perfusion imaging prior to coronary revascularization: From risk stratification to procedure guidance.

Authors:  Patrick Proctor; Firas Al Solaiman; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-07       Impact factor: 5.952

5.  Optimal timing for first-pass stress CT myocardial perfusion imaging.

Authors:  Bernhard Bischoff; Fabian Bamberg; Roy Marcus; Florian Schwarz; Hans-Christoph Becker; Alexander Becker; Maximilian Reiser; Konstantin Nikolaou
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-20       Impact factor: 2.357

6.  Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization.

Authors:  Jiehui Li; Xiubin Yang; Yueqin Tian; Hongxing Wei; Marcus Hacker; Xiang Li; Xiaoli Zhang
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

Review 7.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26

8.  Predictive value of electrocardiography-gated myocardial perfusion imaging to new-onset heart failure in patients with chronic kidney disease: findings from the J-ACCESS 3 study.

Authors:  Mamoru Nanasato; Shinro Matsuo; Kenichi Nakajima; Shigeyuki Nishimura; Tsunehiko Nishimura
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-15       Impact factor: 2.357

Review 9.  Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.

Authors:  Lawrence M Phillips; Rory Hachamovitch; Daniel S Berman; Ami E Iskandrian; James K Min; Michael H Picard; Raymond Y Kwong; Matthias G Friedrich; Marielle Scherrer-Crosbie; Sean W Hayes; Tali Sharir; Gilbert Gosselin; Marco Mazzanti; Roxy Senior; Rob Beanlands; Paola Smanio; Abhi Goyal; Mouaz Al-Mallah; Harmony Reynolds; Gregg W Stone; David J Maron; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

10.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.